As mentioned above, CRABP2 was highly expressed in drug-resistant ovarian cancer cells in the database, which made us wonder whether the correlations between CRABP2 higher expression and malignant progression of ovarian cancer and poor prognosis of patients was related to drug resistance. The gene discussed is CRABP2; the disease is ovarian carcinoma.